Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
about
Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014).Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets.Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests.
P2860
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en-gb
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@nl
type
label
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en-gb
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@nl
prefLabel
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en-gb
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@nl
P2860
P50
P921
P6366
P1154
2-s2.0-85014757393
P1476
Hypofibrinolysis in diabetes: ...... uction of cardiovascular risk.
@en
P2093
Katherine Kearney
Ramzi Ajjan
P2860
P2888
P356
10.1186/S12933-017-0515-9
P407
P5008
P5530
P577
2017-03-09T00:00:00Z
P6179
1084251149
P6366
2592424182